Table of Contents

Global Baclofen Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope

• 1.1 Product Details and Introduction
  • 1.1.1 Tablet 10 mg -Product Introduction and Major Manufacturers
  • 1.1.2 Tablet 20 mg -Product Introduction and Major Manufacturers
• 1.2 Market Snapshot
  • 1.2.1 Major Companies Overview
  • 1.2.2 Market Concentration
  • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Global Baclofen Market Assessment, by Segmentation

• 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
• 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
• 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

3 Regional Market Analysis

• 3.1 China Baclofen Market
  • 3.1.1 Top Companies leading Baclofen Development in China (2015-2020)
  • 3.1.2 Sales Value of Major Company in China Market (2015-2020)
  • 3.1.3 China Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.1.4 Sales in China Market, by Type (2015-2026)
• 3.2 EU Baclofen Market
  • 3.2.1 Top Companies leading Baclofen Development in EU (2015-2020)
  • 3.2.2 Sales Value of Major Company in EU Market (2015-2020)
  • 3.2.3 EU Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.2.4 Sales in EU Market, by Type (2015-2026)
• 3.3 USA Baclofen Market
  • 3.3.1 Top Companies leading Baclofen Development in USA (2015-2020)
  • 3.3.2 Sales Value of Major Company in USA Market (2015-2020)
  • 3.3.3 USA Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.3.4 Sales in USA Market, by Type (2015-2026)
• 3.4 Japan Baclofen Market
  • 3.4.1 Top Companies leading Baclofen Development in Japan (2015-2020)
  • 3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
  • 3.4.3 Japan Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.4.4 Sales in Japan Market, by Type (2015-2026)
• 3.5 India Baclofen Market
  • 3.5.1 Top Companies leading Baclofen Development in India (2015-2020)
  • 3.5.2 Sales Value of Major Company in India Market (2015-2020)
  • 3.5.3 India Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.5.4 Sales in India Market, by Type (2015-2026)
• 3.6 Southeast Asia Baclofen Market
  • 3.6.1 Top Companies leading Baclofen Development in Southeast Asia (2015-2020)
  • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
  • 3.6.3 Southeast Asia Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
• 3.7 South America Baclofen Market
  • 3.7.1 Top Companies leading Baclofen Development in South America (2015-2020)
  • 3.7.2 Sales Value of Major Company in South America Market (2015-2020)
  • 3.7.3 South America Baclofen Price (USD/Unit), by Type (2019-2020)
  • 3.7.4 Sales in South America Market, by Type (2015-2026)

4 Value Chain (Impact of COVID-19)

• 4.1 Baclofen Value Chain Analysis
  • 4.1.1 Upstream
  • 4.1.2 Downstream
• 4.2 COVID-19 Impact on Baclofen Industry
  • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
• 4.3 Cost-Under the Epidemic Situation
  • 4.3.1 Cost of Raw Material
• 4.4 Channel Analysis
  • 4.4.1 Distribution Channel-Under the Epidemic Situation
  • 4.4.2 Distributors

5 Regional Market Forecast (2021-2026)

• 5.1 Global Baclofen Sales and Growth Rate (2021-2026)
• 5.2 Global Baclofen Sales Value and Growth Rate (2021-2026)

6 Baclofen Competitive Analysis

• 6.1 Lannett
  • 6.1.1 Lannett Company Profiles
  • 6.1.2 Lannett Product Introduction
  • 6.1.3 Lannett Baclofen Production, Revenue (2015-2020)
  • 6.1.4 SWOT Analysis
• 6.2 North Star Rx
  • 6.2.1 North Star Rx Company Profiles
  • 6.2.2 North Star Rx Product Introduction
  • 6.2.3 North Star Rx Baclofen Production, Revenue (2015-2020)
  • 6.2.4 SWOT Analysis
• 6.3 Teva Pharmaceuticals
  • 6.3.1 Teva Pharmaceuticals Company Profiles
  • 6.3.2 Teva Pharmaceuticals Product Introduction
  • 6.3.3 Teva Pharmaceuticals Baclofen Production, Revenue (2015-2020)
  • 6.3.4 SWOT Analysis
• 6.4 LGM Pharma
  • 6.4.1 LGM Pharma Company Profiles
  • 6.4.2 LGM Pharma Product Introduction
  • 6.4.3 LGM Pharma Baclofen Production, Revenue (2015-2020)
  • 6.4.4 SWOT Analysis
• 6.5 Qualitest Products
  • 6.5.1 Qualitest Products Company Profiles
  • 6.5.2 Qualitest Products Product Introduction
  • 6.5.3 Qualitest Products Baclofen Production, Revenue (2015-2020)
  • 6.5.4 SWOT Analysis
• 6.6 Par Pharmaceuticals
  • 6.6.1 Par Pharmaceuticals Company Profiles
  • 6.6.2 Par Pharmaceuticals Product Introduction
  • 6.6.3 Par Pharmaceuticals Baclofen Production, Revenue (2015-2020)
  • 6.6.4 SWOT Analysis
• 6.7 Beijing 4A Biotech
  • 6.7.1 Beijing 4A Biotech Company Profiles
  • 6.7.2 Beijing 4A Biotech Product Introduction
  • 6.7.3 Beijing 4A Biotech Baclofen Production, Revenue (2015-2020)
  • 6.7.4 SWOT Analysis
• 6.8 Novartis Pharma Schweiz
  • 6.8.1 Novartis Pharma Schweiz Company Profiles
  • 6.8.2 Novartis Pharma Schweiz Product Introduction
  • 6.8.3 Novartis Pharma Schweiz Baclofen Production, Revenue (2015-2020)
  • 6.8.4 SWOT Analysis

7 Conclusion

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Baclofen market in this environment.

In terms of revenue, this research report indicated that the global Baclofen market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Baclofen industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Lannett aims at producing XX Baclofen in 2020, with XX % production to take place in global market, North Star Rx accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Baclofen Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Baclofen Market?
Lannett
North Star Rx
Teva Pharmaceuticals
LGM Pharma
Qualitest Products
Par Pharmaceuticals
Beijing 4A Biotech
Novartis Pharma Schweiz
...
Major Type of Baclofen Covered in XYZResearch report:
Tablet 10 mg
Tablet 20 mg
Application Segments Covered in XYZResearch Market
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

For any other requirements, please feel free to contact us and we will provide you customized report.